Medicines / Boehringer Ingelheim / Actilyse
ActilyseAlteplase
Actilyse is marketed by Boehringer Ingelheim. 2 packs on NPPA's price list for July 2026, containing Alteplase.
- Packs listed
- 2
- Lowest MRP
- ₹25,125
- Per unit
- ₹1,050 to ₹1,256
- Price-controlled packs
- 0 of 2
- Dosage forms
- 2
Packs and prices
- ₹25,125Actilyse 20 mg Infusion 20 mlAlteplase Infusion 20 mg · ₹1,256 per ml
- ₹52,499Actilyse 50 mg Injection 50 mlAlteplase Injection 50 mg · ₹1,050 per ml
The company
Boehringer Ingelheim has 22 packs on the price list, and CDSCO has named it as the manufacturer of 1 failed batch since Aug 2022. Company record
Prices are the maximum retail prices each company filed with the National Pharmaceutical Pricing Authority (NPPA) for July 2026, read from NPPA's Pharma Sahi Daam service on 2 Oct 2026. A price in a shop can be lower; it may not lawfully be higher. Failed batches are those CDSCO and state laboratories declared not of standard quality. This is a record of prices and filings, not medical advice: do not change a medicine without your doctor or pharmacist. Source: NPPA and CDSCO, Government of India. About this record.